EDIT
Price
$2.96
Change
-$0.00 (-0.00%)
Updated
Oct 29, 12:23 PM (EDT)
Capitalization
453.06M
11 days until earnings call
Intraday BUY SELL Signals
FBIO
Price
$2.04
Change
+$0.08 (+4.08%)
Updated
Oct 29, 12:15 PM (EDT)
Capitalization
65.37M
15 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

EDIT vs FBIO

EDIT vs FBIO Comparison Chart in %
View a ticker or compare two or three
VS
EDIT vs. FBIO commentary
Oct 29, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EDIT is a StrongBuy and FBIO is a Buy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for EDIT with price predictions
Oct 28, 2026

EDIT in upward trend: price rose above 50-day moving average on October 28, 2026

EDIT moved above its 50-day moving average on October 28, 2026 date and that indicates a change from a downward trend to an upward trend. In 32 of 39 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 82%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 27, 2026. You may want to consider a long position or call options on EDIT as a result. In 64 of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 76%.

The Moving Average Convergence Divergence (MACD) for EDIT just turned positive on October 27, 2026. Looking at past instances where EDIT's MACD turned positive, the stock continued to rise in 38 of 48 cases over the following month. The odds of a continued upward trend are 79%.

Following a +22.92% 3-day Advance, the price is estimated to grow further. Considering data from situations where EDIT advanced for three days, in 180 of 225 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where EDIT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

EDIT broke above its upper Bollinger Band on October 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for EDIT entered a downward trend on October 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 44 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 55 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.303) is normal, around the industry mean (3.151). P/E Ratio (-4.470) is within average values for comparable stocks, (-1.051). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (127.720) among similar stocks. P/S Ratio (5.855) is also within normal values, averaging (439.237).

The Tickeron Price Growth Rating for this company is 59 (best 1 - 100 worst), indicating steady price growth. EDIT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EDIT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

A.I.Advisor
a Summary for FBIO with price predictions
Oct 28, 2026

FBIO in upward trend: price expected to rise as it breaks its lower Bollinger Band on October 14, 2026

FBIO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 30 of 35 cases where FBIO's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 86%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where FBIO's RSI Oscillator exited the oversold zone, 34 of 43 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 79%.

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 56 of 68 cases where FBIO's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 82%.

The Momentum Indicator moved above the 0 level on October 28, 2026. You may want to consider a long position or call options on FBIO as a result. In 69 of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 80%.

The Moving Average Convergence Divergence (MACD) for FBIO just turned positive on October 20, 2026. Looking at past instances where FBIO's MACD turned positive, the stock continued to rise in 39 of 52 cases over the following month. The odds of a continued upward trend are 75%.

Following a +4.81% 3-day Advance, the price is estimated to grow further. Considering data from situations where FBIO advanced for three days, in 204 of 255 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FBIO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.

The Aroon Indicator for FBIO entered a downward trend on October 28, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 14 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 57 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.398) is normal, around the industry mean (3.151). P/E Ratio (0.603) is within average values for comparable stocks, (-1.051). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (127.720) among similar stocks. P/S Ratio (1.145) is also within normal values, averaging (439.237).

The Tickeron PE Growth Rating for this company is 65 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 80 (best 1 - 100 worst), indicating slightly worse than average price growth. FBIO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FBIO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

FUNDAMENTALS RATINGS
EDIT vs FBIO: Fundamental Ratings
EDIT
FBIO
OUTLOOK RATING
1..100
9021
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
57
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9914
PRICE GROWTH RATING
1..100
5980
P/E GROWTH RATING
1..100
4465
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

EDIT's Valuation (55) in the Biotechnology industry is in the same range as FBIO (57). This means that EDIT’s stock grew similarly to FBIO’s over the last 12 months.

EDIT's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as FBIO (100). This means that EDIT’s stock grew similarly to FBIO’s over the last 12 months.

FBIO's SMR Rating (14) in the Biotechnology industry is significantly better than the same rating for EDIT (99). This means that FBIO’s stock grew significantly faster than EDIT’s over the last 12 months.

EDIT's Price Growth Rating (59) in the Biotechnology industry is in the same range as FBIO (80). This means that EDIT’s stock grew similarly to FBIO’s over the last 12 months.

EDIT's P/E Growth Rating (44) in the Biotechnology industry is in the same range as FBIO (65). This means that EDIT’s stock grew similarly to FBIO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
EDITFBIO
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
79%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
82%
Momentum
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
80%
MACD
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
75%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
80%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 4 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
86%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
COMPARISON
Comparison
Oct 29, 2026
Stock price -- (EDIT: $2.95 vs. FBIO: $1.96)
Brand notoriety: EDIT and FBIO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EDIT: 155% vs. FBIO: 48%
Market capitalization -- EDIT: $453.06M vs. FBIO: $65.37M
EDIT [@Biotechnology] is valued at $453.06M. FBIO’s [@Biotechnology] market capitalization is $65.37M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $134.26B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EDIT’s FA Score shows that 0 FA rating(s) are green while FBIO’s FA Score has 1 green FA rating(s).

  • EDIT’s FA Score: 0 green, 5 red.
  • FBIO’s FA Score: 1 green, 4 red.
According to our system of comparison, both EDIT and FBIO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EDIT’s TA Score shows that 4 TA indicator(s) are bullish while FBIO’s TA Score has 6 bullish TA indicator(s).

  • EDIT’s TA Score: 4 bullish, 4 bearish.
  • FBIO’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, FBIO is a better buy in the short-term than EDIT.

Price Growth

EDIT (@Biotechnology) experienced а +17.53% price change this week, while FBIO (@Biotechnology) price change was +1.03% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.76%. For the same industry, the average monthly price growth was -6.74%, and the average quarterly price growth was -10.27%.

Reported Earning Dates

EDIT is expected to report earnings on Nov 09, 2026.

FBIO is expected to report earnings on Nov 13, 2026.

Industries' Descriptions

@Biotechnology (+8.76% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
EDIT
Daily Signal:
Gain/Loss:
FBIO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
NVDQ8.990.20
+2.28%
T-Rex 2X Inverse NVIDIA Daily Target ETF (NVDQ)
BLGR32.500.19
+0.59%
Bluemonte Large Cap Growth ETF (BLGR)
YBST11.120.03
+0.28%
GraniteShares YieldBoost Single Stock Universe ETF (YBST)
PJUL50.080.08
+0.16%
Innovator U.S. Equity Power Buffer ETF - July (PJUL)
DDTL22.640.02
+0.07%
Innovator Equity Dual Directional 10 Buffer ETF - July (DDTL)